Result in high-risk patients validates decades of research into mRNA-based therapeutic cancer vaccines.

The review finds that wait times must be shortened, that few people detransition, and that trans youth care has enormous benefits.

On the morning of July 7, 2026, Lorenzo Salgado Araujo was ta… LULAC Institute, Inc. needs your support for In Loving Memory of Lorenzo Salgado Araujo, 52 Years Old